Vertex Pharmaceuticals announced earlier this week that it will acquire Semma Therapeutics, a privately held biotechnology company working on a
Republished with permission from The University of Arizona. Children with Type 1 diabetes have only one option to control their blood sugar: insulin
JDRF, an organization funding Type 1 diabetes research, today announced the launch of the JDRF Northern California Center of Excellence. The new
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: